GlobalData on MSN3d
ElevateBio taps Amazon’s genAI tools to design CRISPR therapeuticsAWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.
ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex ...
ElevateBio will leverage artificial intelligence to expand and accelerate CRISPR discovery, design, and drug development for thousands of complex monogenic and polygenic diseases Generative AI ...
ElevateBio has entered into a multi-year collaboration with Amazon's cloud arm to identify treatment targets and new CRISPR systems.
The world received the first FDA-approved CRISPR therapy in December 2023. Image credit: Shutterstock / Panuwach. ElevateBio has partnered with Amazon Web Services (AWS) to expedite the discovery and ...
"As new studies continue to confirm the widespread presence of PFAS in water systems, consumer products, and environmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback